SEC 8-K filings, classified by Claude with reasoning. Updated nightly from EDGAR's daily index (~10 PM ET).
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Item 2.02 explicitly discloses financial results for the quarter ended March 31, 2026, with a press release furnished as Exhibit 99.1. This is a standard quarterly earnings announcement, which is material to investors assessing the registrant's operational performance and financial condition.
View raw filing on EDGAR →This disclosure reports implementation of a 1-for-10 reverse stock split approved by stockholders, effective May 21, 2026, primarily to achieve Nasdaq minimum bid price compliance. While Item 5.03 covers amendments to articles and bylaws, the reverse stock split is a material capital structure event affecting all shareholders' share counts and potential delisting risk mitigation, but does not fit neatly into the more specific event categories (it is neither a routine bylaw amendment nor a delisting notice itself). The materiality stems from the significant reduction in outstanding shares and the company's apparent compliance pressure.
View raw filing on EDGAR →The filing discloses a reverse stock split announced on May 19, 2026. While reverse stock splits are material corporate actions that affect share structure and are typically disclosed under Item 8.01 (Other Events), this event does not fit neatly into the more specific taxonomy categories. A reverse stock split can signal financial distress or be a technical measure to maintain listing compliance, making it material to investors' assessment of the registrant's financial condition and stock structure.
View raw filing on EDGAR →The filing discloses completion of a material acquisition (the "Merger") of Corvex Legacy Holdings, Inc. by Movano Inc. (now renamed Corvex, Inc.) on March 19, 2026, pursuant to an Amended and Restated Merger Agreement. Although Item 2.02 typically covers financial results, the substance of this disclosure is the consummation of a merger transaction with pro forma financial statements, which is a classic M&A activity event. The filing explicitly references the Merger Agreement and provides pro forma combined financial statements as if the merger had occurred on January 1, 2026/2025, confirming this is a material acquisition completion.
View raw filing on EDGAR →InMed Pharmaceuticals entered into a definitive merger agreement with Mentari Therapeutics on May 19, 2026, whereby Mentari shareholders will receive approximately 98.49% of the combined company post-closing. This is a material acquisition/change of control transaction requiring shareholder approval, Nasdaq listing approval, and SEC registration statement filing. The transaction contemplates a $125 million equity valuation for Mentari and involves a two-step merger structure with concurrent $150 million financing.
View raw filing on EDGAR →Item 5.01 discloses a change in control of the registrant and incorporates Item 1.01 by reference. Item 1.01 covers entry into material acquisition, disposition, merger, or change of control transactions. A change in control is a material event that would significantly affect investor assessment of the registrant's ownership, governance, and strategic direction.
View raw filing on EDGAR →The filing discloses entry into a Merger Agreement between InMed Pharmaceuticals and Mentari, announced via joint press release on May 19, 2026. The disclosure explicitly references "the entry into the Merger Agreement" and describes the proposed merger's structure, timing, financing, and expected combined company operations. This constitutes a material acquisition/change of control event under Item 1.01 or 2.01, even though disclosed under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →Amesite Inc. announced securing a major new enterprise customer with a 2,700-patient census, described as "its largest deployment to date and a major milestone in validating its enterprise strategy." While this is a significant business development, it does not fit neatly into the standard event taxonomy (not an earnings release, M&A activity, or other defined categories). The disclosure is material to investors as it demonstrates validation of the company's enterprise strategy and represents a substantial customer win, but the event type is best classified as other_material given the absence of a more specific category.
View raw filing on EDGAR →The filing discloses a press release issued on May 13, 2026 announcing financial results for the quarter ended March 31, 2026, with an earnings call conducted on May 15, 2026. This is a standard quarterly earnings release disclosure under Item 2.02, which is material to investors as it provides the registrant's financial performance for the period.
View raw filing on EDGAR →The filing discloses a shareholder letter and corporate update issued on May 18, 2026, but the Item 8.01 text itself provides no substantive detail about the content or nature of the update. Without access to Exhibit 99.1, the specific event cannot be precisely classified. Given that a formal shareholder letter and corporate update warrant 8-K disclosure, the event is presumed material, but the lack of descriptive language in the Item text prevents confident assignment to a more specific category.
View raw filing on EDGAR →The filing discloses entry into an amendment to a Business Combination Agreement dated May 15, 2026, between Plum IV, Merger Sub, and Controlled Thermal Resources Holdings Inc. The amendment extends key deadlines for financial statement delivery, antitrust filings, and material consents. This is a material acquisition/change of control transaction involving a SPAC merger, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.
View raw filing on EDGAR →The Compensation Committee approved an increase in compensation for Michael W. West, the Chief Operating Officer, effective March 29, 2026, establishing his fiscal 2027 compensation package: base salary of $425,000, target performance-based cash incentive of 40% of base salary, and target long-term equity incentive of 65% of base salary. This is a direct disclosure of compensatory arrangements for a named executive officer under Item 5.02(e).
View raw filing on EDGAR →The Company discloses that it remains unable to file its Form 10-Q due to "accounting adjustments required by the Company and its auditors in response to SEC comments on the Annual Report on Form 10-K for the financial year ended December 31, 2024." This indicates SEC-driven accounting corrections that cascade through interrelated financial figures in prior and current reports, a hallmark of restatement activity. While the filing does not explicitly use the word "restatement," the disclosure of required accounting adjustments to prior-year financials that prevent current-period filing is material and consistent with restatement disclosure patterns.
View raw filing on EDGAR →Michael W. Bonney was appointed as Chair of the Board effective May 16, 2026, a principal officer position. The disclosure details his extensive executive and board leadership experience across multiple biotechnology companies, including prior CEO roles at Cubist Pharmaceuticals and Kaleido Biosciences. This appointment of a senior board leadership position is material to investors assessing the company's governance and strategic direction.
View raw filing on EDGAR →The filing discloses the appointment of Mr. Bonney as Chair of the Board, announced via press release on May 19, 2026. This is a material executive appointment to a senior governance role. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 5.02, the substance is clearly an executive appointment that would affect a reasonable investor's assessment of the company's leadership structure.
View raw filing on EDGAR →Hancock Whitney Corporation entered into an Agreement and Plan of Merger on May 15, 2026, with OFB Bancshares, Inc., providing for a multi-step merger transaction whereby OFB Bancshares will ultimately merge into Hancock Whitney, followed by a bank-level merger of One Florida Bank into Hancock Whitney Bank. The transaction involves a cash consideration of $29.273 per share and is subject to customary regulatory approvals and shareholder vote. This is a material acquisition/merger activity requiring Item 1.01 disclosure.
View raw filing on EDGAR →Blackstone Mortgage Trust completed a $450 million offering of 6.250% Senior Secured Notes due 2031 under an indenture dated May 19, 2026. While this is a debt issuance rather than a traditional M&A transaction, Item 1.01 covers "Entry into a Material Definitive Agreement," and the indenture governing $450 million in senior secured debt constitutes a material definitive agreement. The company intends to use proceeds for general corporate purposes including paying down existing secured indebtedness, which is material to investors assessing the company's capital structure and leverage profile.
View raw filing on EDGAR →Item 2.03 discloses creation of a direct financial obligation, with details incorporated by reference from Item 1.01. Without access to Item 1.01's content, the specific nature of the obligation cannot be determined. This could represent M&A activity, debt issuance, covenant breach, or another material event. Given the cross-reference structure and the materiality threshold of Item 2.03, this is classified as material but assigned to "other_material" due to insufficient information to select a more specific event type.
View raw filing on EDGAR →The disclosure reports shareholder approval on May 14, 2026 of an amendment to the 2023 Equity Incentive Plan that increases the share reserve by 1,700,000 shares. This is a compensatory arrangement amendment affecting the pool of equity available for director and officer awards, which falls squarely within exec_compensation. The material increase in authorized shares for equity grants would affect investor assessment of dilution and executive compensation capacity.
View raw filing on EDGAR →This Item 5.07 disclosure presents the final voting results from Gentherm's May 14, 2026 annual meeting of shareholders, including election of nine directors, advisory approval of named executive officer compensation, ratification of Ernst & Young LLP as independent auditor, and approval of an amendment to the 2023 Equity Incentive Plan. The tabulated vote counts for each proposal are the hallmark of shareholder_vote_results classification.
View raw filing on EDGAR →STORE Capital completed issuance of $589 million in mortgage-backed notes through special purpose subsidiaries on May 19, 2026, pursuant to a Note Purchase Agreement entered May 14, 2026. While this is a financing transaction rather than a traditional M&A event, Item 1.01 encompasses "Entry into a Material Definitive Agreement," and the company explicitly discloses this as such. The transaction involves material debt issuance ($567M to qualified institutional investors) that will be used to "repay existing indebtedness and to fund growth," making it a material capital structure event. However, this is more accurately characterized as a securitization/financing rather than M&A; the closest taxonomy fit is ma_activity given the Item 1.01 designation and materiality, though other_material would also be defensible.
View raw filing on EDGAR →Item 2.03 incorporates Item 1.01 by reference, indicating a material acquisition, disposition, merger, or change of control transaction. Item 1.01 is the standard disclosure vehicle for M&A activity. While the specific transaction details are not provided in this excerpt, the cross-reference structure and Item 2.03's focus on direct financial obligations created by such transactions strongly suggests an M&A event that creates material financial obligations for the registrant.
View raw filing on EDGAR →The filing discloses an offering of notes announced via press release on May 19, 2026, but the Item 7.01 disclosure itself provides minimal detail—only that a press release was issued and is attached as Exhibit 99.1. Without access to the exhibit text, the specific nature of the offering (debt issuance, convertible notes, etc.) cannot be definitively determined. The disclosure is material to investors as a capital-raising event, but does not fit cleanly into dilutive_issuance (which typically applies to equity) or ma_activity. Classified as other_material pending review of the full press release exhibit.
View raw filing on EDGAR →EagleRock Land, LLC entered into an underwriting agreement on May 13, 2026, for the offer and sale of 17.3 million Class A shares at $18.50 per share, with an additional 2.595 million shares issued via an exercised option, generating approximately $333.1 million in net proceeds. While this is a registered public offering (not an unregistered private placement), the substantial equity issuance and capital raise are material events that would affect investor assessment. The taxonomy's "dilutive_issuance" category emphasizes unregistered sales and PIPEs, but this registered IPO-like offering is the most salient material event disclosed and fits the spirit of equity dilution disclosure, though a registered offering is less typical for this category.
View raw filing on EDGAR →The filing discloses completion of a material reorganization transaction on May 15, 2026, involving multiple contributors transferring subsidiaries and assets to OpCo in exchange for OpCo Units and Class B shares, with assumption of the Predecessor Credit Facility. This constitutes a material acquisition/disposition of assets under Item 2.01, restructuring the company's ownership and asset structure in connection with an offering.
View raw filing on EDGAR →Item 3.02 discloses unregistered sales of equity securities relying on Section 4(a)(2) exemption. The Warrant Exercise Agreement dated May 4, 2026, involved warrant holders exercising L&E Warrants to purchase units and receiving OpCo Units and Class B shares in redemption, followed by merger transactions resulting in issuance of Class A shares. This constitutes a dilutive equity issuance undertaken outside registered offerings, typical of private placements or restructuring transactions involving equity conversion.
View raw filing on EDGAR →Item 3.03 discloses a material modification to rights of security holders, with the substance incorporated by reference from Item 5.03. Without access to Item 5.03's content, the specific nature of the modification cannot be determined; however, any material modification to security holder rights is presumptively material to investors. The cross-reference structure prevents precise classification into a more specific event type.
View raw filing on EDGAR →The filing discloses the appointment of six new directors (Richard H. Coats as chairman, and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed, and Michael Wallace as board members) on May 13, 2026, expanding the Board from a single director (Greg Pipkin Jr.) to seven members. While the section also covers compensatory arrangements (LTIP, ESPP, CIC Severance Plan) and indemnification agreements, the principal disclosed action is the appointment of multiple directors and the material restructuring of the Board in connection with the Offering.
View raw filing on EDGAR →The filing discloses a press release announcing "the pricing of the Offering" on May 13, 2026. While the specific terms are not detailed in the Item 7.01 text itself, the announcement of an offering pricing is a classic signal of a dilutive equity issuance. The furnishing under Regulation FD and the reference to an offering pricing strongly suggest a capital raise that would dilute existing shareholders, consistent with dilutive_issuance classification.
View raw filing on EDGAR →The filing discloses a press release issued on May 19, 2026 discussing financial results for the three months ended March 31, 2026. This is a quarterly earnings release furnished under Item 7.01 (Regulation FD Disclosure). Quarterly financial results are material to investors' assessment of the registrant's performance and are routinely disclosed via 8-K press releases.
View raw filing on EDGAR →The Company entered into three exchange agreements on May 19, 2026, exchanging approximately $22.7 million in aggregate royalty interest reductions for 908 shares of Series Q Perpetual Preferred Stock. This represents a material restructuring of the Company's debt obligations through conversion into equity, which affects the capital structure and is disclosed under Item 1.01 (Material Definitive Agreements). While not a traditional M&A transaction, the scale and nature of the debt-for-equity exchange constitutes a material capital transaction affecting investor assessment of the registrant's financial position.
View raw filing on EDGAR →Item 2.03 discloses creation of a direct financial obligation by incorporating Item 1.01 by reference. Without access to Item 1.01's content, the specific nature of the obligation cannot be determined. The incorporation suggests a material financial event (likely M&A, debt issuance, or similar), but the actual event type cannot be reliably classified without seeing the underlying Item 1.01 disclosure.
View raw filing on EDGAR →Item 3.02 explicitly discloses unregistered sales of equity securities—Common Exchange Shares and Series Q Preferred Stock—issued under Section 3(a)(9) of the Securities Act. This is a classic dilutive issuance event. The incorporation by reference to Item 1.01 suggests a material transaction (likely a debt conversion or exchange), and the use of the Section 3(a)(9) exemption is typical for private equity issuances that signal cash-raising or restructuring activity.
View raw filing on EDGAR →This Item 5.03 discloses the filing of a Certificate of Designation for Series Q Preferred Stock in connection with royalty interest exchange transactions (referenced under Items 1.01 and 3.02). While the primary event is the issuance of preferred stock with complex terms (10% annual preferred return, liquidation preferences, voting rights with a 9.99% cap, and company exchange rights), the Item 5.03 classification itself is administrative. However, the underlying transaction—issuance of 2,000 shares of preferred stock with substantial economic rights and a 10% accruing preferred return—is material to investors. This does not fit neatly into the specific event types (not a simple appointment, departure, or compensation arrangement), so "other_material" is most appropriate.
View raw filing on EDGAR →The disclosure centers on stockholder approval of two compensation plans: the 2026 Long-Term Incentive Plan (9.5 million shares reserved) and the amended ESPP (9.5 million additional shares, totaling 14.4 million reserved). These are material compensatory arrangements for directors and officers designed to "attract and retain employees and non-employee directors" through "stock-based and cash-based incentive compensation," directly matching the exec_compensation taxonomy definition.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports the outcomes of the Annual Meeting held on May 19, 2026, including election of ten directors, advisory vote on executive compensation, ratification of KPMG LLP as auditor, approval of the 2026 LTIP, and approval of the ESPP. Detailed vote tallies (FOR, AGAINST, ABSTAIN, broker non-votes) are provided for each matter, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for five proposals at Dine Brands' 2026 Annual Meeting held May 14, 2026: election of nine directors, ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, advisory approval of special meeting rights at 25% threshold, and a stockholder proposal on 15% threshold special meeting rights. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core content of the disclosure.
View raw filing on EDGAR →Cardiff Oncology filed a lawsuit against Nerviano Medical Sciences in U.S. District Court for the Southern District of California seeking injunctive relief and declaratory judgment regarding an alleged material breach of a license agreement for onvansertib. The dispute centers on patent inventorship obligations and continuation patent applications, with Cardiff disputing NMS's breach allegations. This is a material litigation event that would affect investor assessment of the company's ability to maintain its license rights and product development.
View raw filing on EDGAR →This is a clear disclosure of shareholder meeting voting results under Item 5.07. The filing reports results on three proposals: election of eleven directors (all elected), advisory vote on named executive officer compensation (passed), and ratification of auditor Plante & Moran, LLC (passed). These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →Wayne A. Stevens, President - Retail Banking of Trustmark Bank, notified the Boards of his intention to retire effective July 3, 2026. While the disclosure also mentions acceleration of vesting of restricted stock units, the principal disclosed action is the departure of a long-tenured executive officer (40 years of service, Executive Officer since 2009). The compensatory element (RSU acceleration) is secondary and incidental to the retirement announcement.
View raw filing on EDGAR →The filing discloses stockholder approval of the third amendment to the 2022 ACCO Brands Corporation Incentive Plan, which increases shares available for future grants by 4,100,000 shares and eliminates fungible share counting ratios. This is a material amendment to the company's equity compensation plan that directly affects the pool of shares available for executive and employee awards, making it a compensatory arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →This Item 5.07 disclosure presents the final results of stockholder votes at ACCO Brands' Annual Meeting, including election of nine directors, ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2022 Incentive Plan. The detailed voting tallies (For, Against, Abstain, Broker Non-Vote) for each proposal are the core content of a shareholder vote results disclosure, which is material to investors assessing governance and corporate direction.
View raw filing on EDGAR →The disclosure centers on the Committee's approval of long-term incentive compensation arrangements for NEOs, including performance restricted stock units (PRSUs) and restricted stock grants with specific dollar values (ranging from $175,000 to $1,250,000 per executive) and vesting schedules. This is a classic compensatory arrangement disclosure under Item 5.02(e), distinct from an executive departure or appointment. The re-approval of the amended 2024 Plan is ancillary context supporting the equity grants.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the Company's Annual Meeting held on May 14, 2026, covering four proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, re-approval of the 2024 Long-Term Incentive Plan, and an advisory vote on named executive officer compensation. The filing explicitly states Item 5.07 and presents final voting tallies for each proposal, which is the hallmark of shareholder_vote_results classification.
View raw filing on EDGAR →Sabre issued $150 million of exchangeable senior notes convertible into common stock at an initial exchange price of approximately $2.24 per share. While technically a debt issuance, the exchangeable feature creates significant dilution potential to existing shareholders, particularly given the conversion mechanics and the ability of holders to exchange into common stock. This is a material capital-raising event with equity dilution consequences.
View raw filing on EDGAR →Item 2.03 discloses creation of a direct financial obligation, but the actual substance is incorporated by reference from Item 1.01. Without access to Item 1.01's content, the specific event type cannot be determined with confidence. Item 1.01 typically covers M&A activity, but could also involve debt issuance, lease arrangements, or other financial obligations. Marking as material given the Item 2.03 designation and flagging as "other_material" pending visibility of the referenced Item 1.01 disclosure.
View raw filing on EDGAR →Sabre issued exchangeable notes in a private placement relying on Section 4(a)(2) exemption from registration, with potential dilution of 67–87 million shares of common stock upon exchange. This is a classic unregistered equity issuance (Item 3.02) that materially dilutes existing shareholders and signals capital-raising activity typical of small- to mid-cap issuers under financial pressure.
View raw filing on EDGAR →Sabre entered into privately-negotiated purchase agreements with accredited investors and qualified institutional buyers to issue "New Exchangeable Notes," which are exchangeable into equity and thus dilutive to existing shareholders. The filing discloses that net proceeds were used to repurchase $100 million of existing exchangeable notes, with intent to retire the remaining $50 million, indicating a material capital structure transaction. This is a classic dilutive issuance under Item 3.02 taxonomy, disclosed here under Item 8.01.
View raw filing on EDGAR →The filing discloses entry into a material definitive agreement under Item 1.01, but the actual substance is incorporated by reference from Item 2.03 (Creation of a Direct Financial Obligation). Without the referenced Item 2.03 content, the specific nature of the agreement cannot be determined—it could relate to debt financing, a lease, a credit facility, or other financial obligations. Given the cross-reference structure and the materiality signal from Item 1.01, this is classified as material but as "other_material" due to insufficient detail to assign a more specific event type.
View raw filing on EDGAR →Southwest Airlines entered into an Increase Joinder Agreement on May 19, 2026, that amends its Term Loan Credit Agreement to add $1.0 billion in incremental term loans, bringing total outstanding principal to $1.5 billion. While this is disclosed under Item 2.03 (Creation of a Direct Financial Obligation), the event is primarily a material increase in debt financing secured by aircraft collateral, which would affect investor assessment of the company's leverage and financial position. This does not fit cleanly into the more specific categories (covenant_breach, dilutive_issuance, or ma_activity), making other_material the most appropriate classification.
View raw filing on EDGAR →